Detalhe da pesquisa
1.
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Clin Infect Dis
; 69(8): 1278-1287, 2019 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759187